Delcath Systems, Inc.
1633 Broadway, Suite 22C
New York, New York 10019
September 13, 2022
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
| Re: | Delcath Systems, Inc. |
Registration Statement on Form S-3 Filed September 7, 2022
File No. 333-267321
To whom it may concern:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Delcath Systems, Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-267321) be accelerated by the Securities and Exchange Commission to 4:00 p.m. Washington D.C. time on September 15, 2022 or as soon as practicable thereafter.
The Company requests that we be notified of such effectiveness by a telephone call to Nicolas H.R. Dumont of Cooley LLP at (212) 479-6446 and that such effectiveness also be confirmed in writing.
| Very truly yours, | ||
| Delcath Systems, Inc. | ||
| By: | /s/ Gerard Michel | |
| Gerard Michel | ||
| Chief Executive Officer | ||
| cc: | Ryan Sansom, Cooley LLP Nicolas H.R. Dumont, Cooley LLP |